Company news
Square Pharmaceuticals Plc (DSEBD:SQURPHARMA) news
Square Pharmaceuticals Plc news releases on 6ix. Latest, Apr 29, 2026: SQURPHARMA: Strong revenue and profit growth, with higher EPS and robust operating cash…
Press releases & updates
SQURPHARMA: Strong revenue and profit growth, with higher EPS and robust operating cash flow
April 29, 2026
SQURPHARMA: Six-month net profit surged 16% year-over-year on strong revenue and cash flow growth
January 29, 2026
SQURPHARMA: Consolidated profit up 14.54% with strong exports and a 120% cash dividend; standalone profit dipped
November 20, 2025
SQURPHARMA: Net revenue grew 21.7% and net profit after tax rose 21.5% year-over-year in Q1 FY2025-26
November 12, 2025
SQURPHARMA: Double-digit profit and revenue growth, strong balance sheet, and robust investment income
April 29, 2025
SQURPHARMA: Net profit up 13% to Tk. 12.70B; EPS and NAV per share both increased year-over-year
February 7, 2025
SQURPHARMA: Net profit rose 13% year-over-year, with EPS at Tk. 14.32 and strong asset growth
January 28, 2025
SQURPHARMA: Consolidated profit up 10.26% on strong exports and subsidiary growth; dividend raised
November 24, 2024